Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97


Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1.

Lee MR, Hinton DJ, Wu J, Mishra PK, Port JD, Macura SI, Choi DS.

Neurosci Lett. 2011 Feb 25;490(2):90-5. doi: 10.1016/j.neulet.2010.12.033. Epub 2010 Dec 21.


Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

Hinton DJ, Lee MR, Jacobson TL, Mishra PK, Frye MA, Mrazek DA, Macura SI, Choi DS.

Neuropharmacology. 2012 Jun;62(8):2480-8.


Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling.

Nam HW, Lee MR, Zhu Y, Wu J, Hinton DJ, Choi S, Kim T, Hammack N, Yin JC, Choi DS.

Biol Psychiatry. 2011 Jun 1;69(11):1043-51. doi: 10.1016/j.biopsych.2011.02.013. Epub 2011 Apr 13.


The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference.

Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci A, Messing RO.

Nat Neurosci. 2004 Aug;7(8):855-61. Epub 2004 Jul 18.


Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum.

Nam HW, Hinton DJ, Kang NY, Kim T, Lee MR, Oliveros A, Adams C, Ruby CL, Choi DS.

J Neurosci. 2013 Mar 6;33(10):4329-38. doi: 10.1523/JNEUROSCI.3094-12.2013.


Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats.

Sari Y, Sreemantula SN, Lee MR, Choi DS.

J Mol Neurosci. 2013 Nov;51(3):779-87. doi: 10.1007/s12031-013-0064-y. Epub 2013 Jul 27.


Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1.

Nam HW, Lee MR, Hinton DJ, Choi DS.

Neurosci Lett. 2010 Aug 2;479(3):277-81. doi: 10.1016/j.neulet.2010.05.079. Epub 2010 Jun 4.


Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.

Das SC, Yamamoto BK, Hristov AM, Sari Y.

Neuropharmacology. 2015 Oct;97:67-74. doi: 10.1016/j.neuropharm.2015.05.009. Epub 2015 May 19.


Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice.

Lee MR, Ruby CL, Hinton DJ, Choi S, Adams CA, Young Kang N, Choi DS.

Neuropsychopharmacology. 2013 Feb;38(3):437-45. doi: 10.1038/npp.2012.198. Epub 2012 Oct 3.


Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.

Chau P, Höifödt-Lidö H, Löf E, Söderpalm B, Ericson M.

Alcohol Clin Exp Res. 2010 Jan;34(1):39-45. doi: 10.1111/j.1530-0277.2009.01063.x. Epub 2009 Oct 23.


Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.

Blednov YA, Harris RA.

Int J Neuropsychopharmacol. 2008 Sep;11(6):775-93. doi: 10.1017/S1461145708008584. Epub 2008 Apr 1.


Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1.

Chen J, Nam HW, Lee MR, Hinton DJ, Choi S, Kim T, Kawamura T, Janak PH, Choi DS.

Behav Brain Res. 2010 Apr 2;208(2):636-42. doi: 10.1016/j.bbr.2010.01.011. Epub 2010 Jan 18.


Adenosinergic regulation of striatal clock gene expression and ethanol intake during constant light.

Ruby CL, Vadnie CA, Hinton DJ, Abulseoud OA, Walker DL, O'Connor KM, Noterman MF, Choi DS.

Neuropsychopharmacology. 2014 Sep;39(10):2432-40. doi: 10.1038/npp.2014.94. Epub 2014 Apr 23.


Type 1 equilibrative nucleoside transporter regulates astrocyte-specific glial fibrillary acidic protein expression in the striatum.

Hinton DJ, Lee MR, Jang JS, Choi DS.

Brain Behav. 2014;4(6):903-14. doi: 10.1002/brb3.283. Epub 2014 Sep 19.


Acamprosate-responsive brain sites for suppression of ethanol intake and preference.

Brager A, Prosser RA, Glass JD.

Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1032-43. doi: 10.1152/ajpregu.00179.2011. Epub 2011 Jun 22.


Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures.

Oka M, Hirouchi M, Tamura M, Sugahara S, Oyama T.

Eur J Pharmacol. 2013 Oct 15;718(1-3):323-31. doi: 10.1016/j.ejphar.2013.08.014. Epub 2013 Sep 4.


Strain differences in alcohol-induced neurochemical plasticity: a role for accumbens glutamate in alcohol intake.

Kapasova Z, Szumlinski KK.

Alcohol Clin Exp Res. 2008 Apr;32(4):617-31. doi: 10.1111/j.1530-0277.2008.00620.x. Epub 2008 Mar 13.


Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.

Dahchour A, De Witte P, Bolo N, Nédélec JF, Muzet M, Durbin P, Macher JP.

Psychiatry Res. 1998 May 20;82(2):107-14.


Binge drinking +/- chronic nicotine administration alters extracellular glutamate and arginine levels in the nucleus accumbens of adult male and female Wistar rats.

Lallemand F, Ward RJ, De Witte P, Verbanck P.

Alcohol Alcohol. 2011 Jul-Aug;46(4):373-82. doi: 10.1093/alcalc/agr031. Epub 2011 Apr 9.


The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.

Lidö HH, Marston H, Ericson M, Söderpalm B.

Addict Biol. 2012 Sep;17(5):897-907. doi: 10.1111/j.1369-1600.2011.00367.x. Epub 2011 Sep 28.


Supplemental Content

Support Center